Trial
NCT03632109
Gent for Pharyngeal Gonorrhea (GC)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Washington
Collaborators
National Institute of Allergy and Infectious Diseases (NIAID)
Condition
Pharyngeal Gonococcal Infection
Intervention
gentamicin 360mg IM
Why stopped
Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-10